Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Artesunate by Frantz Viral Therapeutics for Human Papillomavirus Infections: Likelihood of Approval
Artesunate is under clinical development by Frantz Viral Therapeutics and currently in Phase II for Human Papillomavirus Infections. According to...